德诺苏马布
医学
置信区间
优势比
逻辑回归
牙科
混淆
内科学
骨质疏松症
作者
Lolwa Alyahya,Garry L. Myers
标识
DOI:10.1016/j.joen.2020.12.011
摘要
Introduction The objective of this case-control study was to investigate the association between denosumab use and the risk of developing external cervical resorption (ECR). Methods Thirty-three patients ≥45 years old who were diagnosed with ECR were selected. Controls were matched to the cases based on sex and age (±5 years) in a 1:1 ratio. Confounders were classified into systemic factors, including a history of systemic sclerosis, hepatitis B, denosumab use, and bisphosphonate use, or local factors, including a history of traumatic occlusion, periodontal procedures (scaling and root planing and periodontal surgeries), and tooth extraction (excluding third molar extraction). Additionally, the number of remaining teeth in each subject was recorded using panoramic radiographs. The baseline characteristics of the 2 groups, including age, sex, and the number of remaining teeth, were compared using the chi-square and Mann-Whitney U tests. Binary logistic regression was used to determine the possible association between denosumab use and the risk of developing ECR (α < 0.05). Results No significant differences in baseline characteristics were observed between the case and control groups (P > .05). After adjusting for systemic and local cofounders, denosumab use was significantly associated with the occurrence of ECR (odds ratio = 7.317; 95% confidence interval, 1.410–37.966; P < .05). Conclusions Based on the binary logistic regression model, denosumab use could significantly predict the risk of developing ECR.
科研通智能强力驱动
Strongly Powered by AbleSci AI